Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Michael Cucolo is Director of Business Development at Bristol-Myers Squibb Company (BMS) and has worked in the pharmaceutical industry for over 25 years. Michael’s current responsibilities include; the identification, evaluation and licensing of enabling technologies and intellectual property in support of pharmaceutical development drug delivery, applied genomics, immunology and immune-oncology. Michael has experience in supporting discovery virology and neuroscience opportunities. He’s negotiated and executed over 100 diverse transactions. These include material transfers, in-licensing/out-licensing of technology platforms and intellectual property as well as collaborations and consortiums with industry, biotech and academic partners.
During his career, he carried out extensive drug development work on both small chemical entities and biologics for branded and generic pharmaceuticals. He is the inventor on two drug formulation patents and contributed to a number of currently marketed pharmaceuticals.
Michael holds an MS in Biochemistry and Molecular Biology from New York Medical College.